Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, J.
Right arrow Articles by Yang, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, J.
Right arrow Articles by Yang, C. S.
[Cancer Research 62, 7241-7246, December 15, 2002]
© 2002 American Association for Cancer Research


Epidemiology and Prevention

Stability, Cellular Uptake, Biotransformation, and Efflux of Tea Polyphenol (-)-Epigallocatechin-3-Gallate in HT-29 Human Colon Adenocarcinoma Cells1

Jungil Hong, Hong Lu, Xiaofeng Meng, Jae-Ha Ryu, Yukihiko Hara and Chung S. Yang2

Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854 [J. H., H. L., X. M., J-H. R., C. S. Y.], and Food Research Laboratory, Mitsui Norin Co. Ltd., Fujieda, Shizuoka 426-0133, Japan [Y. H.]

The biological effects of (-)-epigallocatechin-3-gallate (EGCG) have been extensively investigated in cell lines, but its stability and interactions with cells under culture conditions are unclear. In the present study, the stability, uptake, biotransformation, and efflux of [3H]EGCG in HT-29 human colon adenocarcinoma cells were investigated. EGCG was unstable in McCoy’s 5A culture media with a half-life of less than 30 min, and the half-life increased to 130 min in the presence of cells. The major oxidative products were theasinensin (Mr 914) and another dimer with Mr 884. Addition of EGCG (50 µM) to cell culture media caused the production of H2O2 (up to 25 µM), and the amount was lower and gradually decreased in the presence of cells. The uptake of EGCG was concentration dependent and did not plateau, even at 640 µM, suggesting a passive diffusion process. Approximately 75% of the [3H]EGCG was found in the cytoplasmic fraction when the cells were incubated with 0.5–20 µM [3H]EGCG for 15 min. The membrane-associated radioactivity increased with time, apparently because of the binding of dimers to the membrane. The accumulation of [3H]EGCG in the cells was significantly higher at 4°C than at 37°C. Multidrug-resistant protein inhibitors, such as indomethacin and probenecid, effectively increased the accumulation of EGCG 4''-glucuronide and 4''-methyl EGCG in the cell. These results suggest that EGCG is metabolized in the cell and that the metabolites are pumped out by MRPs. The present study provides fundamental information on the stability, uptake, biotransformation, and efflux of EGCG under cell culture conditions and suggests the need for careful interpretation of related results on the biological activities of EGCG.




This article has been cited by other articles:


Home page
Anticancer ResHome page
T.-C. HSIEH and J. M. WU
Targeting CWR22Rv1 Prostate Cancer Cell Proliferation and Gene Expression by Combinations of the Phytochemicals EGCG, Genistein and Quercetin
Anticancer Res, October 1, 2009; 29(10): 4025 - 4032.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. D. Lambert, S.-J. Kwon, J. Ju, M. Bose, M.-J. Lee, J. Hong, X. Hao, and C. S. Yang
Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate
Carcinogenesis, October 1, 2008; 29(10): 2019 - 2024.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
H. Dreger, M. Lorenz, A. Kehrer, G. Baumann, K. Stangl, and V. Stangl
Characteristics of Catechin- and Theaflavin-Mediated Cardioprotection
Experimental Biology and Medicine, April 1, 2008; 233(4): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Umeda, S. Yano, K. Yamada, and H. Tachibana
Green Tea Polyphenol Epigallocatechin-3-gallate Signaling Pathway through 67-kDa Laminin Receptor
J. Biol. Chem., February 8, 2008; 283(6): 3050 - 3058.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. D. Lambert, M.-J. Lee, L. Diamond, J. Ju, J. Hong, M. Bose, H. L. Newmark, and C. S. Yang
DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
Drug Metab. Dispos., January 1, 2006; 34(1): 8 - 11.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile
Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Hou, S. Sang, H. You, M.-J. Lee, J. Hong, K.-V. Chin, and C. S. Yang
Mechanism of Action of (-)-Epigallocatechin-3-Gallate: Auto-oxidation-Dependent Inactivation of Epidermal Growth Factor Receptor and Direct Effects on Growth Inhibition in Human Esophageal Cancer KYSE 150 Cells
Cancer Res., September 1, 2005; 65(17): 8049 - 8056.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Kim, A. Murakami, K. Kawabata, and H. Ohigashi
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells
Carcinogenesis, September 1, 2005; 26(9): 1553 - 1562.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Nakazato, K. Ito, Y. Ikeda, and M. Kizaki
Green Tea Component, Catechin, Induces Apoptosis of Human Malignant B Cells via Production of Reactive Oxygen Species
Clin. Cancer Res., August 15, 2005; 11(16): 6040 - 6049.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. D Lambert, J. Hong, G.-y. Yang, J. Liao, and C. S Yang
Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 284S - 291S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. S. Yang, J. Hong, Z. Hou, and S. Sang
Green Tea Polyphenols: Antioxidative and Prooxidative Effects
J. Nutr., November 1, 2004; 134(11): 3181S - 3181S.
[Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. Vittal, Z. E. Selvanayagam, Y. Sun, J. Hong, F. Liu, K.-V. Chin, and C. S. Yang
Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray
Mol. Cancer Ther., September 1, 2004; 3(9): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lorenz, S. Wessler, E. Follmann, W. Michaelis, T. Dusterhoft, G. Baumann, K. Stangl, and V. Stangl
A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation
J. Biol. Chem., February 13, 2004; 279(7): 6190 - 6195.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Yamamoto, J. Lewis, J. Wataha, D. Dickinson, B. Singh, W. B. Bollag, E. Ueta, T. Osaki, M. Athar, G. Schuster, et al.
Roles of Catalase and Hydrogen Peroxide in Green Tea Polyphenol-Induced Chemopreventive Effects
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 317 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. B. Vaidyanathan and T. Walle
Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 745 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Yamamoto, S. Hsu, J. Lewis, J. Wataha, D. Dickinson, B. Singh, W. B. Bollag, P. Lockwood, E. Ueta, T. Osaki, et al.
Green Tea Polyphenol Causes Differential Oxidative Environments in Tumor versus Normal Epithelial Cells
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 230 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. D. Lambert and C. S. Yang
Mechanisms of Cancer Prevention by Tea Constituents
J. Nutr., October 1, 2003; 133(10): 3262S - 3267.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Chen, G. Shen, V. Hebbar, R. Hu, E. D. Owuor, and A.-N.T. Kong
Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells
Carcinogenesis, August 1, 2003; 24(8): 1369 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Hsu, W. B. Bollag, J. Lewis, Q. Huang, B. Singh, M. Sharawy, T. Yamamoto, and G. Schuster
Green Tea Polyphenols Induce Differentiation and Proliferation in Epidermal Keratinocytes
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 29 - 34.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. Lu, X. Meng, C. Li, S. Sang, C. Patten, S. Sheng, J. Hong, N. Bai, B. Winnik, C.-T. Ho, et al.
Glucuronides of Tea Catechins: Enzymology of Biosynthesis and Biological Activities
Drug Metab. Dispos., April 1, 2003; 31(4): 452 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.